share_log

康哲藥業：關於在二零二四年五月九日舉行的股東週年大會的投票結果公告

CMS: ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 9 MAY 2024

Hong Kong Stock Exchange ·  May 9 21:01
Summary by Futu AI
康哲藥業於2024年5月9日召開股東週年大會，會上所有提呈決議案均獲正式通過。該公司於2024年4月2日至24日期間購回約0.5082%的已發行股份，並將進行註銷。股東大會上，共有2,439,528,512股賦予投票權，並無股東根據上市規則放棄投票。會議通過的重要決議包括批准末期股息、董事重選、授權購回公司股份、續聘核數師及修訂公司組織章程大綱及細則等。所有董事均出席了這次會議。
康哲藥業於2024年5月9日召開股東週年大會，會上所有提呈決議案均獲正式通過。該公司於2024年4月2日至24日期間購回約0.5082%的已發行股份，並將進行註銷。股東大會上，共有2,439,528,512股賦予投票權，並無股東根據上市規則放棄投票。會議通過的重要決議包括批准末期股息、董事重選、授權購回公司股份、續聘核數師及修訂公司組織章程大綱及細則等。所有董事均出席了這次會議。
Conge Pharmaceuticals held its Annual General Meeting on 9 May 2024, and all proposed resolutions were formally approved at the meeting. The Company repurchased approximately 0.5082% of the issued shares between April 2 and 24, 2024 and will be written off. At the General Meeting, a total of 2,439,528,512 shares were granted voting rights and no shareholders abstained under the Listing Rules. IMPORTANT RESOLUTIONS PASSED AT THE MEETING INCLUDE APPROVAL OF FINAL DIVIDENDS, RE-ELECTION OF DIRECTORS, AUTHORIZATION TO REPURCHASE COMPANY SHARES, RENEWAL OF AUDITORS AND AMENDMENTS TO THE COMPANY'S ARTICLES OF ASSOCIATION AND ARTICLES OF ASSOCIATION. All directors attended the meeting.
Conge Pharmaceuticals held its Annual General Meeting on 9 May 2024, and all proposed resolutions were formally approved at the meeting. The Company repurchased approximately 0.5082% of the issued shares between April 2 and 24, 2024 and will be written off. At the General Meeting, a total of 2,439,528,512 shares were granted voting rights and no shareholders abstained under the Listing Rules. IMPORTANT RESOLUTIONS PASSED AT THE MEETING INCLUDE APPROVAL OF FINAL DIVIDENDS, RE-ELECTION OF DIRECTORS, AUTHORIZATION TO REPURCHASE COMPANY SHARES, RENEWAL OF AUDITORS AND AMENDMENTS TO THE COMPANY'S ARTICLES OF ASSOCIATION AND ARTICLES OF ASSOCIATION. All directors attended the meeting.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.